A. Agrawal and U. A. Bhosale, “A prospective pharmacovigilance study to evaluate adverse effect profile of first line anti-tubercular drugs in newly diagnosed sputum positive patients”, Int J Basic Clin Pharmacol, vol. 7, no. 2, pp. 283–287, Jan. 2018.